NCT01337258View on ClinicalTrials.gov

Economic Analyses of the REDUCE Trial

CompletedOBSERVATIONAL

Enrollment

1

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Neoplasms, ProstateBenign Prostatic HyperplasiaCancer

Interventions

DRUG

Dutasteride

dutasteride 0.5mg daily.

DRUG

Placebo

Men taking placebo daily

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01337258 - Economic Analyses of the REDUCE Trial | Biotech Hunter | Biotech Hunter